| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri; and the 2Department of Ophthalmology, University of Louisville, Louisville, Kentucky.
PURPOSE. Define a role for Fas-FasL in oxygen-induced retinopathy and explore the mechanism of pigment-epithelium-derived growth factor (PEDF) inhibition in this model.
METHODS. Seven-day-old mice C57BL/6J (B6), FasL-defective (B6-gld), or Fas-defective (B6-lpr) mice were exposed to 75% oxygen for 5 days (postnatal day [P]7–P12) and returned to room air. On day P17, vascular architecture was assessed microscopically after perfusion with FITC-dextran, and preretinal nuclei were quantified by PAS and hematoxylin staining. In some experiments, mice were treated intraperitoneally with PEDF. Vascular architecture and preretinal nuclei counts were compared with those in PBS-treated control animals.
RESULTS. Oxygen-induced retinopathy was significantly increased in FasL-defective gld mice compared with wild-type B6 animals. This was manifested by an increase in the number of microaneurysms, neovascular tufts, and preretinal nuclei. PEDF treatment prevented retinopathy in B6, B6-gld, and B6-lpr mice.
CONCLUSIONS. Fas-FasL interactions regulate the extent of oxygen-induced retinal neovascularization. The inhibition of neovascularization in B6 gld, and B6-lpr mice by PEDF suggests that Fas-FasL interactions are probably not the mechanism for inhibition in this model.
This article has been cited by other articles:
|
|
 |
|
  M. H. Davies, A. J. Stempel, and M. R. Powers MCP-1 Deficiency Delays Regression of Pathologic Retinal Neovascularization in a Model of Ischemic Retinopathy Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4195 - 4202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-C. Ho, S.-L. Chen, Y.-C. Yang, C.-L. Liao, H.-C. Cheng, and Y.-P. Tsao PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells Cardiovasc Res, November 1, 2007; 76(2): 213 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shen, B. Xie, A. Dong, M. Swaim, S. F. Hackett, and P. A. Campochiaro In Vivo Immunostaining Demonstrates Macrophages Associate with Growing and Regressing Vessels Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4335 - 4341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Qiao, K.-H. Sonoda, Y. Ikeda, T. Yoshimura, K. Hijioka, Y.-J. Jo, Y. Sassa, C. Tsutsumi-Miyahara, Y. Hata, S. Akira, et al. Interleukin-18 regulates pathological intraocular neovascularization J. Leukoc. Biol., April 1, 2007; 81(4): 1012 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Semkova, S. Fauser, A. Lappas, N. Smyth, N. Kociok, B. Kirchhof, M. Paulsson, V. Poulaki, and A. M. Joussen Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization FASEB J, August 1, 2006; 20(10): 1689 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Herndon, P. M. Stuart, and T. A. Ferguson Peripheral Deletion of Antigen-Specific T Cells Leads to Long-Term Tolerance Mediated by CD8+ Cytotoxic Cells J. Immunol., April 1, 2005; 174(7): 4098 - 4104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Apte, R. A. Barreiro, E. Duh, O. Volpert, and T. A. Ferguson Stimulation of Neovascularization by the Anti-angiogenic Factor PEDF Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4491 - 4497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Barreiro, G. Luker, J. Herndon, and T. A. Ferguson Termination of Antigen-Specific Immunity by CD95 Ligand (Fas Ligand) and IL-10 J. Immunol., August 1, 2004; 173(3): 1519 - 1525. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
